Zobrazeno 1 - 10
of 181
pro vyhledávání: '"O, Di Munno"'
Autor:
M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti
Publikováno v:
Reumatismo, Vol 69, Iss 1, Pp 30-39 (2017)
Osteoporosis and fractures are common and invalidating consequences of chronic glucorticoid (GC) treatment. Reliable information regarding the epidemiology of GC induced osteoporosis (GIOP) comes exclusively from the placebo group of randomized clini
Externí odkaz:
https://doaj.org/article/f717f6764b0642069eeb137985402106
Autor:
M. Mazzantini, O. Di Munno
Publikováno v:
Reumatismo, Vol 66, Iss 2, Pp 144-152 (2014)
Glucocorticoids are the most common cause of secondary osteoporosis leading to the so-called glucocorticoidinduced osteoporosis (GIO). A treatment with 10 mg/d of prednisone or equivalent for more than 3 months leads to a 7-fold increase in hip fract
Externí odkaz:
https://doaj.org/article/4fa4aea5902242aa8829c8d6862f7848
Autor:
A. Delle Sedie, O. Di Munno
Publikováno v:
Reumatismo, Vol 63, Iss 2, Pp 67-79 (2011)
Osteoporosis (OP) and increased risk of fracture (Fx) associated with chronic glucocorticoid treatment pushed panels of experts and scientific societies to produce recommendations for both prevention and treatment of glucocorticoid-induced OP (GIO).
Externí odkaz:
https://doaj.org/article/085a9ec4f11c413896e14134feef7383
Autor:
M. Antonelli, L. Sinigaglia, O. Di Munno, G. Bianchi, S. Adami, M. Rossini, B. Frediani, G. Minisola
Publikováno v:
Reumatismo, Vol 58, Iss 4, Pp 314-318 (2011)
The fundamental role of Vitamin D has been long known in regulating calcium homeostasis and bone metabolism. An increased contribution of Vitamin D was recently described in association with a lower incidence of Rheumatoid Arthritis (RA). This must n
Externí odkaz:
https://doaj.org/article/0d7827a9ba3c440195bf26a05c8956b5
Autor:
G.P. Pasero, O. Di Munno
Publikováno v:
Reumatismo, Vol 54, Iss 3 (2002)
Objective: To evaluate the therapeutic action and safety of lornoxicam, a new non steroidal anti-inflammatory drug, in 2 oral daily dose regimens of 8 and 16 mg in comparison with oral diclofenac 150 mg/day in patients with rheumatoid arthritis. Meth
Externí odkaz:
https://doaj.org/article/4195b15e645d46f1aade969ed71c3a46
Autor:
O. Di Munno, P. Delvino, Ombretta Viapiana, Walter Grassi, Nazzarena Malavolta, Maurizio Rossini, R. Nuti, Bruno Frediani, Clodoveo Ferri, Gianantonio Saviola, Maurizio Muratore, Francesco Paolo Cantatore, L. Mirone, A. Mathieu, Gianfranco Ferraccioli, Laura Bogliolo, Ilaria Piazza, Maria Vitiello, G. La Montagna, C. U. Manzini, S. Maddali Bongi, A. Del Puente, Davide Gatti, Gaia Tripi
Publikováno v:
Reumatismo, Vol 69, Iss 1, Pp 30-39 (2017)
Osteoporosis and fractures are common and invalidating consequences of chronic glucorticoid (GC) treatment. Reliable information regarding the epidemiology of GC induced osteoporosis (GIOP) comes exclusively from the placebo group of randomized clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170e80594f2ae181dacfb9a996e2f46e
http://hdl.handle.net/11588/694642
http://hdl.handle.net/11588/694642
Publikováno v:
Clinical Rheumatology. 18:140-144
In order to assess the clinical equivalence between deflazacort oral drops and tablets, 18 patients with active rheumatoid arthritis were enrolled in an open, controlled, randomised (‘tablets → drops’ sequence, or vice versa), two-period (21 da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1987a480ebb33f9ca0b9269e770065
https://doi.org/10.1007/s100670050072
https://doi.org/10.1007/s100670050072
Autor:
O. Di Munno, B Cortet, P Oriente, Stefan Goemaere, R Laan, Stephane Horlait, Christian Roux, J Ittner, Jean-Michel Pouilles, R A Hughes
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:1128-1133
Osteoporosis is a well-recognized adverse effect of corticosteroid therapy. This study aimed to investigate the effect of etidronate, intermittent cyclical therapy, in the prevention of corticosteroid-induced bone loss. Patients with various medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::341e6e896efdbf16685b1494e6e80344
https://doi.org/10.1210/jcem.83.4.4742
https://doi.org/10.1210/jcem.83.4.4742
Publikováno v:
Clinical Rheumatology. 14:663-666
To evaluate the effects of the short-term, high-dose sodium heparin therapy on biochemical markers of bone metabolism, we studied 20 patients (11 males and 9 females) with pulmonary embolism, treated with sodium heparin (daily dose range: 40,000-45,0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cd3babad9e690913913f05d73a6fc8
https://doi.org/10.1007/bf02207933
https://doi.org/10.1007/bf02207933
Publikováno v:
Rivista di Neuroradiologia. 16:85-87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ac00e361b5bfeb193932716f90eb6bb
https://doi.org/10.1177/19714009030160s131
https://doi.org/10.1177/19714009030160s131